F. Bonella (Düsseldorf, Germany), C. McCarthy (Dublin 4, Ireland)
Tolerance and efficacy of antifibrotic treatments in IPF patients carriying telomere related gene mutations
A. Justet (Paris , France), D. Klay (Utrecht, Netherlands), V. Cottin (Lyon, France), M. Molina Molina (Barcelona, Spain), H. Nunes (Bobigny, France), M. Reynaud-Gaubert (Marseille, France), J. Naccache (Paris , France), E. Manali (Athens, Greece), A. Froidure (Bruxelles, France), S. Jouneau ( Rennes, Belgium), L. Wemeau (Lille, France), C. Andrejak (Amiens , France), A. Gondouin (Besançon, France), S. Hirschi (Strasbourg, France), B. Bondue (Bruxelles , Belgium), P. Bonniaud (Dijon , France), C. Tromeur (Brest, France), G. Prevost (Toulouse, France), S. Marchand-Adam (Tours, France), M. Funke-Chambour (Bern, Switzerland), A. Gamez (Montpellier, France), C. Kanengiesser (Paris, France), C. Van Moorsel (Utrecht, Netherlands), B. Crestani (Paris, France), R. Borie (Paris , France)
|    |
Clinical impact of BRAFV600E mutation in adult pulmonary Langerhans cell histiocytosis
A. Tazi (Paris, France), F. Jouenne (Paris, France), E. Bugnet (Paris, France), G. Lorillon (Paris, France), V. Meignin (Paris, France), A. Sadoux (Paris, France), S. Chevret (Paris, France), S. Mourah (Paris, France)
| |
Effectiveness of various therapy regimens for patients with pulmonary Langerhans cell histiocytosis during long-term follow-up
A. Zinchenko (Saint-Petersburg, Russian Federation), L. Novikova (Saint-Petersburg, Russian Federation), M. Ilkovich (Saint-Petersburg, Russian Federation)
| |
Natural history of incidental sporadic or tuberous sclerosis complex associated lymphangioleiomyomatosis
F. Di Marco (Milano, Italy), S. Terraneo (Milano, Italy), O. Olívia Meira Dias (Sao Paulo, Brazil), G. Imeri (Milan, Italy), S. Centanni (Milan, Italy), L. Giuliani (Milan, Italy), E. Lesma (Milan, Italy), G. Palumbo (Milan, Italy), M. Wanderley (Sao Paulo, Brazil), C. Ribeiro Carvalho (Sao Paulo, Brazil), B. Guedes Baldi (Sao Paulo, Brazil)
| |
Early-onset therapy with sirolimus helps to improve prognosis of patients with lymphangioleiomyomatosis (LAM)
M. Klingenberg (Hannover, Germany), J. Freise (Hannover, Germany), J. Fuge (Hannover, Germany), T. Welte (Hannover, Germany)
|  |
Pulmonary Alveolar Microlithiasis ~ Epidemiology in Japan and Developing treatment strategies in a novel mouse model ~
A. Saito (Sapporo, Japan), R. Takamiya (Tokyo, Japan), N. Fujitani (Sapporo, Japan), S. Ariki (Sapporo, Japan), K. Kuronuma (Sapporo, Japan), H. Chiba (Sapporo, Japan), M. Takahashi (Sapporo, Japan), H. Takahashi (Sapporo, Japan)
| |
Disease patterns in connective tissue disease-associated interstitial lung disease: a population based study
C. Hyldgaard (Silkeborg, Denmark), E. Bendstrup (Aarhus, Denmark), A. Pedersen (Aarhus, Denmark), L. Pedersen (Aarhus, Denmark), T. Ellingsen (Odense, Denmark)
| |